AR015435A1 - USO DE UN ANÁLOGO POLIPEPTíDICO DEL PÉPTIDO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHRP) Y DE SALES DEL MISMO EN LA PREPARACIoN DE UN MEDICAMENTO. - Google Patents

USO DE UN ANÁLOGO POLIPEPTíDICO DEL PÉPTIDO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHRP) Y DE SALES DEL MISMO EN LA PREPARACIoN DE UN MEDICAMENTO.

Info

Publication number
AR015435A1
AR015435A1 ARP980104456A ARP980104456A AR015435A1 AR 015435 A1 AR015435 A1 AR 015435A1 AR P980104456 A ARP980104456 A AR P980104456A AR P980104456 A ARP980104456 A AR P980104456A AR 015435 A1 AR015435 A1 AR 015435A1
Authority
AR
Argentina
Prior art keywords
pthrp
salts
preparation
peptid
same
Prior art date
Application number
ARP980104456A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR015435A1 publication Critical patent/AR015435A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ARP980104456A 1997-09-09 1998-09-07 USO DE UN ANÁLOGO POLIPEPTíDICO DEL PÉPTIDO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHRP) Y DE SALES DEL MISMO EN LA PREPARACIoN DE UN MEDICAMENTO. AR015435A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5832497P 1997-09-09 1997-09-09

Publications (1)

Publication Number Publication Date
AR015435A1 true AR015435A1 (es) 2001-05-02

Family

ID=22016113

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104456A AR015435A1 (es) 1997-09-09 1998-09-07 USO DE UN ANÁLOGO POLIPEPTíDICO DEL PÉPTIDO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHRP) Y DE SALES DEL MISMO EN LA PREPARACIoN DE UN MEDICAMENTO.

Country Status (31)

Country Link
US (1) US6583114B2 (https=)
EP (1) EP1005359B1 (https=)
JP (1) JP2002509854A (https=)
KR (1) KR100679778B1 (https=)
CN (1) CN1210059C (https=)
AR (1) AR015435A1 (https=)
AT (1) ATE297754T1 (https=)
AU (1) AU752925B2 (https=)
BR (1) BR9812068A (https=)
CA (1) CA2302255C (https=)
CO (1) CO4890856A1 (https=)
CZ (1) CZ298701B6 (https=)
DE (1) DE69830591T2 (https=)
ES (1) ES2244090T3 (https=)
HR (1) HRP20000109A2 (https=)
HU (1) HU226866B1 (https=)
IL (2) IL134719A0 (https=)
MA (1) MA26545A1 (https=)
MY (1) MY121291A (https=)
NO (1) NO323740B1 (https=)
NZ (1) NZ502970A (https=)
PE (1) PE117399A1 (https=)
PL (1) PL195703B1 (https=)
RS (1) RS49707B (https=)
RU (1) RU2224539C2 (https=)
SA (1) SA98190565B1 (https=)
TR (1) TR200000649T2 (https=)
TW (1) TW552139B (https=)
UY (1) UY25172A1 (https=)
WO (1) WO1999012561A2 (https=)
ZA (1) ZA988030B (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2873A1 (fr) * 1998-08-19 2003-12-15 Lilly Co Eli Procédé pour augmenter la dureté et la rigidité osseuse.
EP1769804B1 (en) * 1998-08-19 2012-09-19 Eli Lilly And Company hPTH(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human
US20040033950A1 (en) 2000-09-26 2004-02-19 Hock Janet M. Method of increasing bone toughness and stiffness and reducing fractures
EP1295605A3 (en) * 1998-08-19 2003-10-29 Eli Lilly And Company Method of increasing bone toughness and stiffness and reducing fractures
CA2245903A1 (en) * 1998-09-28 2000-03-28 Mcgill University Use of pex in the treatment of metabolic bone diseases
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6560487B1 (en) 2000-05-08 2003-05-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
US6393328B1 (en) * 2000-05-08 2002-05-21 International Rehabilitative Sciences, Inc. Multi-functional portable electro-medical device
US6675048B2 (en) * 2000-05-08 2004-01-06 International Rehabilitative Sciences, Inc. Electro-medical device for use with biologics
AU2003207512B2 (en) 2002-01-10 2008-06-12 Osteotrophin Llc Treatment of bone disorders with skeletal anabolic drugs
WO2005041998A1 (en) 2003-10-02 2005-05-12 Ali Sadat M Peptide for promoting healing of fractures
AU2005294125A1 (en) * 2004-10-08 2006-04-20 Transition Therapeutics Inc. Vasoactive intestinal polypeptide pharmaceuticals
CN101355959B (zh) * 2005-11-10 2013-02-27 密歇根理工大学管理委员会 黑熊甲状旁腺素和使用黑熊甲状旁腺素的方法
WO2007133580A2 (en) * 2006-05-09 2007-11-22 Zelos Therapeutics, Inc. Use of pth (1-31) and optionally g-csf for hematopoietic stimulation
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
KR101512377B1 (ko) 2006-10-03 2015-04-28 라디우스 헬쓰, 인코포레이티드 골 아나볼릭 단백질을 위한 약물 전달 방법
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
JP5564167B2 (ja) * 2008-05-22 2014-07-30 日本たばこ産業株式会社 苦味マスキング剤及び苦味低減方法
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2411038B1 (en) 2009-03-27 2016-12-28 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
EP2509996A1 (en) 2009-12-07 2012-10-17 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
FI3834824T3 (fi) 2014-03-28 2025-12-05 Univ Duke Estrogeenireseptoripositiivisen rintasyövän hoito selektiivisellä estrogeenireseptorin modulaattorilla
CN104146961B (zh) * 2014-07-04 2018-02-27 深圳职业技术学院 一种薄膜蒸发法制备载细胞因子和骨蛋白微球的方法
JP7019422B2 (ja) 2015-04-29 2022-02-15 ラジウス ファーマシューティカルズ，インコーポレイテッド 癌を治療するための方法
WO2017007777A2 (en) * 2015-07-06 2017-01-12 Zhengxin Dong NOVEL FORMULATIONS OF PTHrP ANALOGUE
EP3481414B1 (en) 2016-04-18 2021-11-03 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
KR102707399B1 (ko) 2017-01-05 2024-09-13 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
IL279853B2 (en) 2018-07-04 2025-01-01 Radius Pharmaceuticals Inc Polymorphic forms of RAD 1901-2HCL
CN113348163B (zh) 2019-02-12 2024-10-08 雷迪厄斯制药公司 方法和化合物
MX2022002979A (es) 2019-09-12 2022-06-16 Radius Health Inc Metodos para mejorar la fusion vertebral con abaloparatida.
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
AU2022205801A1 (en) * 2021-01-05 2023-07-13 Radius Health, Inc. Treatment of long bone fractures with abaloparatide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3935738A1 (de) * 1989-10-27 1991-05-08 Forssmann Wolf Georg Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
US5821225A (en) * 1992-07-14 1998-10-13 Syntex (U.S.A.) Inc. Method for the treatment of corticosteroid induced osteopenia comprising administration of modified PTH or PTHrp
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
US5589452A (en) * 1992-07-14 1996-12-31 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
GB9308033D0 (en) * 1993-04-19 1993-06-02 Sandoz Ltd Organic compounds
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
WO1995002610A1 (en) * 1993-07-13 1995-01-26 Syntex (U.S.A.) Inc. Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
AU8002994A (en) * 1993-10-27 1995-05-22 Chugai Seiyaku Kabushiki Kaisha Cure accelerator in chondroplasty
JPH08310965A (ja) * 1995-05-16 1996-11-26 Chugai Pharmaceut Co Ltd 骨癒合促進剤
US5717062A (en) * 1995-06-07 1998-02-10 Beth Israel Hospital Association Cyclic analogs of PTH and PTHrP
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone

Also Published As

Publication number Publication date
WO1999012561A9 (en) 2000-03-16
YU12700A (sh) 2004-09-03
CO4890856A1 (es) 2000-02-28
CZ2000862A3 (cs) 2000-09-13
KR20010023795A (ko) 2001-03-26
NO20001195L (no) 2000-03-08
HK1030753A1 (zh) 2001-05-18
WO1999012561A3 (en) 1999-05-14
CN1210059C (zh) 2005-07-13
DE69830591D1 (de) 2005-07-21
SA98190565B1 (ar) 2006-07-30
NO323740B1 (no) 2007-07-02
UY25172A1 (es) 2001-01-31
WO1999012561A2 (en) 1999-03-18
EP1005359A2 (en) 2000-06-07
KR100679778B1 (ko) 2007-02-07
IL134719A0 (en) 2001-04-30
TR200000649T2 (tr) 2000-09-21
ATE297754T1 (de) 2005-07-15
ES2244090T3 (es) 2005-12-01
HUP0004560A2 (hu) 2001-04-28
CN1269726A (zh) 2000-10-11
HU226866B1 (en) 2009-12-28
PL195703B1 (pl) 2007-10-31
IL134719A (en) 2010-04-29
DE69830591T2 (de) 2006-05-04
CZ298701B6 (cs) 2007-12-27
BR9812068A (pt) 2000-09-26
MY121291A (en) 2006-01-28
PL339449A1 (en) 2000-12-18
AU9740698A (en) 1999-03-29
TW552139B (en) 2003-09-11
RS49707B (sr) 2007-12-31
RU2224539C2 (ru) 2004-02-27
MA26545A1 (fr) 2004-12-20
NZ502970A (en) 2002-03-01
EP1005359B1 (en) 2005-06-15
ZA988030B (en) 1999-03-09
US20020077281A1 (en) 2002-06-20
CA2302255C (en) 2011-11-08
NO20001195D0 (no) 2000-03-08
CA2302255A1 (en) 1999-03-18
PE117399A1 (es) 1999-11-20
HUP0004560A3 (en) 2005-11-28
AU752925B2 (en) 2002-10-03
US6583114B2 (en) 2003-06-24
HRP20000109A2 (en) 2001-02-28
JP2002509854A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
AR015435A1 (es) USO DE UN ANÁLOGO POLIPEPTíDICO DEL PÉPTIDO RELACIONADO CON LA HORMONA PARATIROIDEA (PTHRP) Y DE SALES DEL MISMO EN LA PREPARACIoN DE UN MEDICAMENTO.
ES2190244T3 (es) Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales.
RU2000109305A (ru) ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР)
AR024074A1 (es) FRAGMENTO ABETA UNIDO A UN PÉPTIDO PORTADOR PARA PREVENIR O TRATAR ENFERMEDADES ASOCIADAS CON DEPoSITOS AMILOIDES DE ABETA, COMPOSICIONES FARMACÉUTICAS QUE LO CONTIENEN, Y SU USO EN LA PREPARACION DE MEDICAMENTOS.
HUP0000299A1 (hu) Késleltetett hatóanyag-leadású gyógyszerkészítmények
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
ES2167365T3 (es) Vectores adenovirales de origen animal y utilizacion en terapia genica.
JP2002509854A5 (https=)
KR20140047043A (ko) PTH, PTHrP를 위한 약물 전달 방법 및 관련 펩티드
ES2193159T3 (es) Una formulacion de factor de coagulacion viii.
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
DK1001802T3 (da) Farmaceutisk kombinationspræparat af parathyroidhormon og en knogleresorptionsinhibitor
JPH06502863A (ja) ２成分型骨粗鬆症用薬剤
BR9811755A (pt) Peptìdeo, processo para o tratamento da obesidade em um animal, uso de um peptìdeo, e, composição farmacêutica
NO20025157L (no) Kreftterapi
BR0109279A (pt) Antagonistas de lhrh, sua preparação e aplicação como medicamento
RU2005131578A (ru) Аплидин для лечения множественной миеломы
JP6897971B2 (ja) 関節炎を処置するための、方法および組成物
BR112021016571A2 (pt) Peptídeo isolado, composição farmacêutica, dispositivo médico implantável, uso de um peptídeo e biomaterial de preenchimento ósseo
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
ECSP982660A (es) USO DE ANALOGOS DEL PTHrP EN LA CICATRIZACION DE FRACTURAS
AR012702A1 (es) Combinacion de (-)-(1s,4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]- 2-ciclopenteno-1-metanol y un inhibidor dee transcriptasa reversa no nucleosidouna formulacion farmaceutica que comprende la combinacion, su uso medico en terapia para tratar la infeccion de vih, y un empaque para el paciente
TH40579A (th) การสมานรอยหักของกระดูกโดยใช้อานาลอกของ PTHrP
TH50339B (th) การสมานรอยหักของกระดูกโดยใช้อานาลอกของ PTHrP
KR102494794B1 (ko) 여성 성기능장애의 치료를 위한 약학 조성물 및 방법

Legal Events

Date Code Title Description
FB Suspension of granting procedure